ATE335524T1 - Verwendung von neurophilin liganden zur behandlung von augenerkrankungen - Google Patents

Verwendung von neurophilin liganden zur behandlung von augenerkrankungen

Info

Publication number
ATE335524T1
ATE335524T1 AT00980231T AT00980231T ATE335524T1 AT E335524 T1 ATE335524 T1 AT E335524T1 AT 00980231 T AT00980231 T AT 00980231T AT 00980231 T AT00980231 T AT 00980231T AT E335524 T1 ATE335524 T1 AT E335524T1
Authority
AT
Austria
Prior art keywords
eye diseases
treat eye
neurophilin ligands
neurophilin
ligands
Prior art date
Application number
AT00980231T
Other languages
English (en)
Inventor
Iok-Hou Pang
Mark A Hellberg
Abdelmoula Namil
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Application granted granted Critical
Publication of ATE335524T1 publication Critical patent/ATE335524T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT00980231T 1999-11-12 2000-10-24 Verwendung von neurophilin liganden zur behandlung von augenerkrankungen ATE335524T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16513799P 1999-11-12 1999-11-12

Publications (1)

Publication Number Publication Date
ATE335524T1 true ATE335524T1 (de) 2006-09-15

Family

ID=22597584

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00980231T ATE335524T1 (de) 1999-11-12 2000-10-24 Verwendung von neurophilin liganden zur behandlung von augenerkrankungen

Country Status (16)

Country Link
US (1) US20060083774A1 (de)
EP (1) EP1227859B1 (de)
JP (1) JP2003514015A (de)
AR (1) AR034103A1 (de)
AT (1) ATE335524T1 (de)
AU (1) AU784347B2 (de)
BR (1) BR0015486A (de)
CA (1) CA2386579A1 (de)
CY (1) CY1106232T1 (de)
DE (1) DE60029985T2 (de)
DK (1) DK1227859T3 (de)
ES (1) ES2269206T3 (de)
HK (1) HK1046108B (de)
PT (1) PT1227859E (de)
TW (1) TW200511984A (de)
WO (1) WO2001035948A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021178977A1 (en) * 2020-03-06 2021-09-10 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Compositions and methods for treating ocular disorders

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260059A (en) * 1989-04-14 1993-11-09 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon Health Sciences University Treatment of open-angle glaucoma by modulation matrix metalloproteinases and their inhibitor
US5922773A (en) * 1992-12-04 1999-07-13 The Children's Medical Center Corp. Glaucoma treatment
US5798355A (en) * 1995-06-07 1998-08-25 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity
US5710165A (en) * 1994-07-06 1998-01-20 Synthelabo Use of polyamine antagonists for the treatment of glaucoma
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5696135A (en) * 1995-06-07 1997-12-09 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US5614547A (en) * 1995-06-07 1997-03-25 Guilford Pharmaceuticals Inc. Small molecule inhibitors of rotamase enzyme
US5856329A (en) * 1995-06-28 1999-01-05 Allergan Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
US5801187A (en) * 1996-09-25 1998-09-01 Gpi-Nil Holdings, Inc. Heterocyclic esters and amides
US5786378A (en) * 1996-09-25 1998-07-28 Gpi Nil Holdings, Inc. Heterocyclic thioesters
US5811434A (en) * 1996-11-13 1998-09-22 Vertex Pharmacueticals Incorporated Methods and compositions for stimulating neurite growth
US5840736A (en) * 1996-11-13 1998-11-24 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5780484A (en) * 1996-11-13 1998-07-14 Vertex Pharmaceuticals Incorporated Methods for stimulating neurite growth with piperidine compounds
US5721256A (en) * 1997-02-12 1998-02-24 Gpi Nil Holdings, Inc. Method of using neurotrophic sulfonamide compounds
US5846979A (en) * 1997-02-28 1998-12-08 Gpi Nil Holdings, Inc. N-oxides of heterocyclic esters, amides, thioesters, and ketones
US5877211A (en) * 1997-11-21 1999-03-02 Allergan EP2 receptor agonists as neuroprotective agents for the eye
ATE238792T1 (de) * 1998-02-23 2003-05-15 Fujisawa Pharmaceutical Co Verwendung von makroliden zur behandlung von glaukom
US6399648B1 (en) * 1998-08-14 2002-06-04 Gpi Nil Holdings, Inc. N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders
CA2335815A1 (en) * 1998-08-14 2000-02-24 Hansjorg Sauer Compositions and uses for vision and memory disorders

Also Published As

Publication number Publication date
EP1227859A2 (de) 2002-08-07
DK1227859T3 (da) 2006-12-11
US20060083774A1 (en) 2006-04-20
PT1227859E (pt) 2006-12-29
EP1227859B1 (de) 2006-08-09
TW200511984A (en) 2005-04-01
CY1106232T1 (el) 2011-06-08
WO2001035948A3 (en) 2002-01-17
BR0015486A (pt) 2002-07-02
DE60029985D1 (de) 2006-09-21
AU784347B2 (en) 2006-03-16
HK1046108A1 (en) 2002-12-27
HK1046108B (en) 2007-01-05
CA2386579A1 (en) 2001-05-25
JP2003514015A (ja) 2003-04-15
AU1752201A (en) 2001-05-30
ES2269206T3 (es) 2007-04-01
AR034103A1 (es) 2004-02-04
WO2001035948A2 (en) 2001-05-25
DE60029985T2 (de) 2007-02-01

Similar Documents

Publication Publication Date Title
ATE419856T1 (de) Verwendung von rimexolon zur behandlung von augentrockenheit
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
ATE417602T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE69903543D1 (de) Formulierungen zur behandlung von magen-speiseröhren reflux
DE69918687D1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
DE60015516D1 (de) Verwendung von makroliden zur behandlung von trockenen augen
ATE300597T1 (de) Behandlung von geweben
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
ATE292134T1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
ATE482676T1 (de) Skleraprothese zur behandlung der weitsichtigkeit und anderer augenkrankheiten
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
DE60136748D1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
EP1239851A4 (de) Behandlung von hyperproliferativen erkrankungen
DE60030861D1 (de) Verwendung von escitalopram zur Behandlung von generalisierten Angstzuständen
ATE289196T1 (de) Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen
ATE270102T1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
ATE259155T1 (de) Verfahren zur verwendung von emamectin zur behandlung von fisch-parasiten
ATE330596T1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
DE59704933D1 (de) Verwendung von PHMB zur Behandlung von Tumorerkrankungen
DE60138371D1 (de) PROSTAGLANDINE zur Behandlung von Lichtstrahlung erzeugten Augenerkrankungen wie Photoretinitis
DE60017174D1 (de) Rivastigmine zur behandlung von augenerkrankungen
DE69924284D1 (de) Verwendung von stimulatoren der neurotrophischen faktoren zur behandlung von neurodegenerativen ophthalmischen krankheiten
ATE404203T1 (de) Verwendung von desoxypeganin zur behandlung der klinischen depression
DE60120961D1 (de) Disulfid-derivate verwendbar zur behandlung von allergischen erkrankungen
DE60005685D1 (de) Oxazinocarbazole zur behandlung von cns-erkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1227859

Country of ref document: EP